Skip to content
Medical Health Aged Care

Social prescribing can be a ‘script against loneliness’: RACGP

Royal Australian College of GPs 3 mins read

As Loneliness Awareness Week comes to a close, the Royal Australian College of GPs (RACGP) has supported the value of social prescribing as a health intervention that helps patients connect more and improve their overall health.

Loneliness is recognised as a public health priority for many countries around the world. A recent World Health Organisation (WHO) report found as many as one in six people experience loneliness, a “discrepancy between one’s desired and actual experience of social connection” that can be a temporary response or chronic and intractable.

The WHO estimates loneliness led to 871,000 deaths globally each year from 2014–2019. It may increase the risk of all-cause mortality in older adults by 9–22%, with deeper social isolation increasing risk by 32–33%.

A separate report from Ending Loneliness Together found 43% of young Australians aged 15–25 experience loneliness, and for 15% of them, loneliness was chronic, persisting across two years.

RACGP President Dr Michael Wright said the health effects of loneliness are clear and welcomed the growing recognition of social prescribing – connecting patients to non-medical activities to support health – as an intervention.

“Loneliness Awareness Week highlights the significance and the importance of social connection to our health,” he said.

“Key risks factors for poor health, including chronic illness and mental health issues, social isolation, a lack of activity, and a lack of connection with others. Social disconnection can also lead to heart disease, stroke, depression, and anxiety. One study found that lacking social connection is as dangerous as smoking up to 15 cigarettes a day.

“Social connection should be, and increasingly is, a public health priority.

“Social prescribing is increasingly being recognised as a way to build social wellbeing into primary care, which we saw when the RACGP joined more than 50 other key health bodies to work towards implementation of social prescribing as a parallel system of care last year.

“Loneliness Awareness Week has highlighted the harms. What GPs and patients need is support to implement social prescribing as a cure.”

Earlier in the year, the RACGP called for greater use of social prescribing in Australia, particularly in rural and remote areas, and a recent Australian Journal of General Practice article discussed its feasibility and barriers to adoption.

RACGP Specific Interests Social Prescribing Chair Dr Kuljit Singh said the approach needs support, but can reinforce GPs’ role as specialists in preventive and whole-of-person care.

“As GPs, we and our patients discuss lifestyle options and behavioural changes that support health,” she said.

“Social prescribing can strengthen and complement our care in a way that gives patients power and autonomy. Social groups to support exercise, hobbies that build lasting connections – the social structures that support health.

“Social prescribing can be a health approach to addressing the social disconnection we’ve seen since the pandemic – a script against loneliness.

“At the moment, there are barriers to more formal adoption of social prescribing. Most general practices don’t have access to a link worker who can match patients to activities that meet their social needs. GPs aren’t funded to provide non-medical care or get to know local community services.

“But support is growing. The WHO published a toolkit to support implementation of social prescribing in 2022 and this year the Victorian Government has been trialling a social prescribing program, Local Connections, across six regions.

“And we can implement social prescribing as an add-on to what we’re already doing, ahead of the creation of systems to support social prescribing.

“If you know about a group in your community that has a hobby a patient might enjoy, it’s an opportunity to enhance the care you provide. If practice team members have an interest, it can be an opportunity to connect with the community, like we’ve seen with practice parkruns.

“There are opportunities to build networks that support social prescribing. And the nature of social prescribing – making healthy connections around your interests – makes it an approach with real advantages that we all benefit from growing.”

~ENDS


About us:

The Royal Australian College of General Practitioners (RACGP) is the peak representative organisation for general practice, the backbone of Australia’s health system. We set the standards for general practice, facilitate lifelong learning for GPs, connect the general practice community, and advocate for better health and wellbeing for all Australians.

Visit www.racgp.org.au. To unsubscribe from RACGP media releases, click here.


Contact details:

John Ronan
Senior Media Advisor

Stuart Winthrope
Media Advisor

Kevin Diggerson
Public Affairs Manager

Contact: 03 8699 0992[email protected]

Follow us on X and Facebook.

Media

More from this category

  • Medical Health Aged Care
  • 16/06/2026
  • 14:30
Dementia Australia

Brisbane comes together for people impacted by dementia

Brisbane community members tied up their laces and showed up in force last weekend for the 2026 Brisbane Memory Walk & Jog - throwing their support behind people impacted by dementia whilst getting active to improve their brain health. More than 1,470 people walked, ran and jogged to the finish line to raise an impressive total of $195,098. Dementia Australia CEO Professor Tanya Buchanan extended her gratitude to all who participated, volunteered and raised vital funds for the cause. “There was an incredible turnout from the Brisbane community this year yet again, in support of the many people impacted by…

  • Contains:
  • Biotechnology, Medical Health Aged Care
  • 16/06/2026
  • 09:51
ENA Respiratory

ENA Respiratory Receives USPTO Notice of Allowance for Two Patents Covering TLR2 Agonists and Rhinovirus-Mediated COPD Exacerbations

Melbourne, Australia, 15 June 2026 – ENA Respiratory, a clinical-stage pharmaceutical company developing innate immune modulators for the prevention of complications associated with respiratory viral infections in at-risk populations, announces today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for two patent applications notably a composition-of-matter patent and method-of-use for its Toll-like receptor 2 (TLR2) therapies. A composition-of-matter patent (US 17/622,451, "A series of TLR2 agonist compounds") and A method-of-use patent for the treatment of rhinovirus-mediated exacerbations of chronic obstructive pulmonary disease (COPD) (US 16/495,829, "Methods of treating rhinovirus-mediated exacerbations of COPD…

  • Medical Health Aged Care
  • 16/06/2026
  • 08:35
Neuroscience Research Australia (NeuRA)

Review provides latest evidence on low back pain assessment and treatment

Key Facts: · Latest evidence on low back pain finds most patients don’t need scans, surgery or strong medicines. · Researchers from Neuroscience Research Australia (NeuRA), UNSW Sydney and the US worked on the review of hundreds of studies to provide clinicians with an up-to-date guide to the assessment and management of low back pain. · It’s hoped the review will provide practical guidance for clinical care and assist patients in receiving tests and treatments that work.Low back pain affects around 619 million people worldwide, but a new review suggests many are receiving unnecessary scans and ineffectual treatments. Researchers compiled…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.